Physician profile
David S Lao
NPI 1487817383
$11,428.87
in general payments reported to CMS, 2019-2025
19 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,004 · 2020: $1,037 · 2021: $1,835 · 2022: $2,301 · 2023: $2,469 · 2024: $1,629 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,252.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,811.74 | 2021-2025 | Symplicity G3, Telescope, Ffrangio |
| Boston Scientific Corporation | $2,759.40 | 2019-2025 | General - Balloon Catheters, Avvigo Guidance System, Synergy |
| Abiomed | $1,570.96 | 2019-2025 | Impella |
| Inari Medical, INC. | $1,267.90 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $858.27 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $532.81 | 2019-2024 | Lifevest |
| Artivion, INC. | $372.96 | 2020 | |
| Medtronic Vascular, INC. | $304.09 | 2019-2020 | |
| Chiesi USA, INC. | $245.75 | 2019-2022 | |
| Stryker Corporation | $155.80 | 2025 | Flowtriever, Flowsaver, Artix Mt |
| Abbott Laboratories | $129.37 | 2022 | |
| Linvatec Corporation | $110.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $65.68 | 2019-2020 | |
| Cardiovascular Systems INC. | $51.48 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $51.30 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $48.00 | 2025 | Repatha |
| Terumo Medical Corporation | $44.76 | 2021-2023 | Optitorque, Glidewire |
| Edwards Lifesciences Corporation | $31.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.